These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38777883)

  • 1. Assessment of MR blood-oxygen-level-dependent (BOLD) cerebrovascular reactivity under general anesthesia in children with moyamoya.
    Choi EJ; Levin D; Robertson A; Kirkham FJ; Muthusami P; Krishnan P; Shroff M; Moharir M; Dirks P; MacGregor D; Pulcine E; Bhathal I; Kassner A; Walker K; Allan W; deVeber G; Logan WJ; Dlamini N
    Pediatr Radiol; 2024 Jul; 54(8):1325-1336. PubMed ID: 38777883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breath-Hold Blood Oxygen Level-Dependent MRI: A Tool for the Assessment of Cerebrovascular Reserve in Children with Moyamoya Disease.
    Dlamini N; Shah-Basak P; Leung J; Kirkham F; Shroff M; Kassner A; Robertson A; Dirks P; Westmacott R; deVeber G; Logan W
    AJNR Am J Neuroradiol; 2018 Sep; 39(9):1717-1723. PubMed ID: 30139753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measurement of Cerebrovascular Reactivity as Blood Oxygen Level-Dependent Magnetic Resonance Imaging Signal Response to a Hypercapnic Stimulus in Mechanically Ventilated Patients.
    Venkatraghavan L; Poublanc J; Han JS; Sobczyk O; Rozen C; Sam K; Duffin J; Mikulis DJ; Fisher JA
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):301-308. PubMed ID: 28967593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrovascular Reactivity Mapping Using Resting-State BOLD Functional MRI in Healthy Adults and Patients with Moyamoya Disease.
    Liu P; Liu G; Pinho MC; Lin Z; Thomas BP; Rundle M; Park DC; Huang J; Welch BG; Lu H
    Radiology; 2021 May; 299(2):419-425. PubMed ID: 33687287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of cerebrovascular reactivity using real-time BOLD fMRI in children with moyamoya disease: a pilot study.
    Thomas B; Logan W; Donner EJ; Shroff M
    Childs Nerv Syst; 2013 Mar; 29(3):457-63. PubMed ID: 23132694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of cerebrovascular reserve in patients with cerebrovascular diseases using resting-state MRI: A feasibility study.
    Taneja K; Lu H; Welch BG; Thomas BP; Pinho M; Lin D; Hillis AE; Liu P
    Magn Reson Imaging; 2019 Jun; 59():46-52. PubMed ID: 30849484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of cerebrovascular reactivity by blood oxygen level-dependent MR imaging and correlation with conventional angiography in patients with Moyamoya disease.
    Heyn C; Poublanc J; Crawley A; Mandell D; Han JS; Tymianski M; terBrugge K; Fisher JA; Mikulis DJ
    AJNR Am J Neuroradiol; 2010 May; 31(5):862-7. PubMed ID: 20075092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior Infarcts, Reactivity, and Angiography in Moyamoya Disease (PIRAMD): a scoring system for moyamoya severity based on multimodal hemodynamic imaging.
    Ladner TR; Donahue MJ; Arteaga DF; Faraco CC; Roach BA; Davis LT; Jordan LC; Froehler MT; Strother MK
    J Neurosurg; 2017 Feb; 126(2):495-503. PubMed ID: 26967789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presurgical Magnetic Resonance Imaging Indicators of Revascularization Response in Adults With Moyamoya Vasculopathy.
    L Waddle S; Garza M; Davis LT; V Chitale R; R Fusco M; A Lee C; Patel NJ; Kang H; Jordan LC; Donahue MJ
    J Magn Reson Imaging; 2022 Oct; 56(4):983-994. PubMed ID: 35289460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the effect of unilateral cerebral revascularisation on the vascular reactivity of the non-intervened hemisphere: a retrospective observational study.
    Sam K; Poublanc J; Sobczyk O; Han JS; Battisti-Charbonney A; Mandell DM; Tymianski M; Crawley AP; Fisher JA; Mikulis DJ
    BMJ Open; 2015 Feb; 5(2):e006014. PubMed ID: 25673438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement of cerebrovascular reactivity in pediatric patients with cerebral vasculopathy using blood oxygen level-dependent MRI.
    Han JS; Mikulis DJ; Mardimae A; Kassner A; Poublanc J; Crawley AP; deVeber GA; Fisher JA; Logan WJ
    Stroke; 2011 May; 42(5):1261-9. PubMed ID: 21493907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A practical modification to a resting state fMRI protocol for improved characterization of cerebrovascular function.
    Stickland RC; Zvolanek KM; Moia S; Ayyagari A; Caballero-Gaudes C; Bright MG
    Neuroimage; 2021 Oct; 239():118306. PubMed ID: 34175427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of abnormal cerebrovascular reactivity on BOLD fMRI: a preliminary investigation of moyamoya disease.
    Mazerolle EL; Ma Y; Sinclair D; Pike GB
    Clin Physiol Funct Imaging; 2018 Jan; 38(1):87-92. PubMed ID: 27572110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliable quantification of BOLD fMRI cerebrovascular reactivity despite poor breath-hold performance.
    Bright MG; Murphy K
    Neuroimage; 2013 Dec; 83():559-68. PubMed ID: 23845426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping cerebrovascular reactivity using blood oxygen level-dependent MRI in Patients with arterial steno-occlusive disease: comparison with arterial spin labeling MRI.
    Mandell DM; Han JS; Poublanc J; Crawley AP; Stainsby JA; Fisher JA; Mikulis DJ
    Stroke; 2008 Jul; 39(7):2021-8. PubMed ID: 18451352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-based cerebrovascular reactivity using transfer function analysis reveals temporal group differences between patients with sickle cell disease and healthy controls.
    Leung J; Duffin J; Fisher JA; Kassner A
    Neuroimage Clin; 2016; 12():624-630. PubMed ID: 27722086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolonged Mean Transit Time Detected by Dynamic Susceptibility Contrast Magnetic Resonance Imaging Predicts Cerebrovascular Reserve Impairment in Patients with Moyamoya Disease.
    Kawano T; Ohmori Y; Kaku Y; Muta D; Uekawa K; Nakagawa T; Amadatsu T; Kasamo D; Shiraishi S; Kitajima M; Kuratsu J
    Cerebrovasc Dis; 2016; 42(1-2):131-8. PubMed ID: 27088711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous phase-contrast MRI and PET for noninvasive quantification of cerebral blood flow and reactivity in healthy subjects and patients with cerebrovascular disease.
    Ishii Y; Thamm T; Guo J; Khalighi MM; Wardak M; Holley D; Gandhi H; Park JH; Shen B; Steinberg GK; Chin FT; Zaharchuk G; Fan AP
    J Magn Reson Imaging; 2020 Jan; 51(1):183-194. PubMed ID: 31044459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Ischemic Risk Using Blood Oxygen Level-Dependent MRI in Children with Moyamoya.
    Dlamini N; Slim M; Kirkham F; Shroff M; Dirks P; Moharir M; MacGregor D; Robertson A; deVeber G; Logan W
    AJNR Am J Neuroradiol; 2020 Jan; 41(1):160-166. PubMed ID: 31806596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Routine clinical evaluation of cerebrovascular reserve capacity using carbogen in patients with intracranial stenosis.
    Donahue MJ; Dethrage LM; Faraco CC; Jordan LC; Clemmons P; Singer R; Mocco J; Shyr Y; Desai A; O'Duffy A; Riebau D; Hermann L; Connors J; Kirshner H; Strother MK
    Stroke; 2014 Aug; 45(8):2335-41. PubMed ID: 24938845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.